Lilly Settles Zyprexa Claims With Another 7 States

Bloomberg is reporting that Eli Lilly has settled claims brought against it by seven states concerning the company's marketing of its antipsychotic Zyprexa. Right now, the settlements are confidential (details should come out later), so it's not possible to tell what states are involved or how much money Lilly is paying out. Most of the claims involved illegal off-label marketing of the drug for use in the elderly and children and the bilking of states' Medicaid programs.

Lilly told the wire service that it's in "advanced discussions" with the other states. A trial involving claims brought by South Carolina is set to begin in October.

Lilly has previously settled various claims brought by individuals, states and the feds for a whopping $2.7 billion.